Who invested in Transcode Therapeutics

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$26Mraised across 2 rounds since 2025, from 2 sources

$20MRound$6.0MDebt

Latest round: Debt, $6.0MApr 2026
Biggest round: $20MRound · Oct 2025
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026

$20MRound$6.0MDebt

First round: Round, $20M
Biggest round: $20M
Between rounds: 6 months

The rounds

Apr 2026
Debt$6.0M3 returning
Source recorded
Oct 2025
Round$20M3 new
Source recorded

Founders and team

From Transcode Therapeutics's own website: 3 on the team.

Elizabeth A. CzerepakCFO, Director
Tania MontgomeryCofounder/Chief Scientific Officer
Jack E. StoverDirector

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2025Debt2026

National Institutes of HealthNational Cancer Institute (NCI)Red Cedar Ventures

Everyone who backed them

National Institutes of HealthGovernment2rounds

National Cancer Institute (NCI)Investment firm2rounds

Red Cedar VenturesVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Transcode Therapeutics

Who invested in Transcode Therapeutics?

Transcode Therapeutics's investors include National Institutes of Health, National Cancer Institute (NCI) and Red Cedar Ventures.

How much has Transcode Therapeutics raised?

Transcode Therapeutics has raised $26M across 2 rounds since 2025.

When did Transcode Therapeutics last raise?

Transcode Therapeutics's most recent round was a Debt of $6.0M in Apr 2026.

What was Transcode Therapeutics's biggest round?

Transcode Therapeutics's largest round on record is $20M (Undisclosed round), in Oct 2025.

Who backed Transcode Therapeutics first?

Transcode Therapeutics's first round on record, in Oct 2025, was backed by National Institutes of Health, National Cancer Institute (NCI) and Red Cedar Ventures.